Geneprodx
Date | Investors | Amount | Round |
---|---|---|---|
N/A | $3.0m | Series A | |
N/A | N/A | Series A | |
$3.2m | Series A | ||
Total Funding | CAD8.5m |
Recent News about Geneprodx
EditGeneproDX is a biotechnology company specializing in precision medicine to enhance the quality of life for millions of patients globally. Founded in 2015 by Dr. Hernan Gonzalez, the company operates in the healthcare diagnostics market, focusing on thyroid nodule diagnosis. GeneproDX serves healthcare providers and patients by offering advanced genomic tests powered by artificial intelligence. These tests ensure accurate diagnosis, lower healthcare costs, and prevent unnecessary surgeries. The business model revolves around selling diagnostic tests to medical institutions and clinics, generating revenue through test sales and potential partnerships with healthcare providers. By leveraging cutting-edge technology, GeneproDX aims to transform the future of precision medicine.
Keywords: precision medicine, genomics, artificial intelligence, thyroid diagnosis, healthcare diagnostics, biotechnology, unnecessary surgeries, healthcare providers, diagnostic tests, medical innovation.